Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Addiction Treatment Services-BBRC, Johns Hopkins Bayview Medical Center, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA.
Addict Behav. 2010 May;35(5):499-503. doi: 10.1016/j.addbeh.2009.12.033. Epub 2010 Jan 4.
The present study evaluated psychiatric distress as a predictor of treatment enrollment in out-of-treatment injection opioid users newly registered at the Baltimore Needle Exchange Program (BNEP). Study participants (n=281) completed the Addiction Severity Index (ASI), the Risk Assessment Battery (RAB), and the Symptom Checklist-90 (SCL-90-R), and were randomly assigned to one of three different conditions for 4 months that evaluated referral strategies designed to promote treatment interest and enrollment. The Global Severity Index (GSI) of the SCL-90 was used as a measure of psychiatric distress. A logistic regression showed that higher GSI scores predicted more treatment enrollment (Adjusted OR=2.15, CI=1.10-4.23, p<0.05), after controlling for study condition, demographic variables, syringe exchange site, and severity of drug use. The results suggest that the data from the assessment of psychiatric distress in syringe exchange settings can be used to support motivational strategies for encouraging syringe exchangers to seek substance abuse treatment.
本研究评估了精神疾病困扰作为预测因素，对新登记在巴尔的摩注射类阿片药物滥用者外展治疗项目（BNEP）的未经治疗的注射类阿片药物使用者，预测其接受治疗的可能性。研究参与者（n=281）完成了成瘾严重程度指数（ASI）、风险评估工具（RAB）和症状清单-90（SCL-90-R），并随机分配到 4 个月的三种不同条件，评估旨在促进治疗意愿和登记的转介策略。SCL-90 的全球严重程度指数（GSI）被用作精神疾病困扰的衡量标准。逻辑回归显示，在控制研究条件、人口统计学变量、注射器交换地点和药物使用严重程度后，较高的 GSI 分数预测了更多的治疗登记（调整后的 OR=2.15，CI=1.10-4.23，p<0.05）。结果表明，从注射器交换环境中评估精神疾病困扰的数据可以用于支持动机策略，鼓励注射器交换者寻求药物滥用治疗。
